Inspiring & original thinking. And, the latest news about us.
Welcome to Well Filtered™
A blog series dedicated to unearthing the ideas, perspectives, and innovations that matter most in kidney health.
- Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States 01.26.23
- Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems 01.09.23
- Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes 12.01.22
- Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023 11.30.22
- Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease 11.29.22
- Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30 11.22.22
- Renalytix to Present at Stifel Healthcare Conference 11.03.22
- Renalytix Reports Full Year Fiscal 2022 Results 10.31.22
- Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31 10.24.22
- KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology 10.17.22